Received Oct 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | — |
No additional AE reported.; CAPVAXIVE was administered to a 1 year old patient; This spontaneous report was received from a nurse and refers to a 1-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 15-Oct-2025, the patient of 1 year was vaccinated Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE), 0.5 mL (0.5 mL), (lot # and expiration date were not reported) for prophylaxis (Product administered to patient of inappropriate age). The nurse denied any vaccine reaction at time of call; no additional AE reported (no adverse event).